Related Experiment Video
Updated: Jun 7, 2025

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Association Between Atrial Fibrillation and Long-term Mortality in Acute MI Patients
Ferdinand Bauke1,2, Christa Meisinger1, Philip Raake2
1Epidemiology, Medical Faculty, University of Augsburg Augsburg, Germany.
Background:
AF is a common complication of an acute MI (AMI) and goes along with adverse events. Nevertheless, the therapeutical guidelines and pharmacological possibilities have improved over the past years. Therefore, this contemporary study aimed to clarify the effect of AF on long-term mortality in patients with incident AMI.
Methods:
This study included 2,313 patients aged 25-84 years with initial AMI that occurred from 2009 until 2017, documented within the population-based Augsburg Myocardial Infarction Registry. Patients were monitored from hospital admission, with a median follow-up duration of 4.5 years (interquartile range 4.4 years). Survival analysis and multivariable Cox regression analysis were conducted to explore the relationship between AF and long-term all-cause and cardiovascular disease mortality.
Results:
Altogether, 156 individuals had AF on their admission ECG, while the remaining 2,157 presented with sinus rhythm (SR). Patients with AF were significantly older, more frequently had arterial hypertension, non-ST-segment elevation MI, worse kidney function, smaller AMIs, and were more often former and non-smokers. An increased long-term all-cause mortality was observed among the AF group. (AF patients 39.1%, SR group 16.7%), Upon multivariable adjustment, a HR of 1.40 (95% CI [1.05-1.87]; p=0.023) was calculated when comparing the AF with SR patients.
Conclusion:
An independently increased risk of long-term mortality for patients with AF compared with patients with SR in case of incident AMI was identified. Therefore, AF should be considered as a serious risk factor in AMI patients, and must be treated aggressively to reduce mortality risk.
Insights
Atrial fibrillation (AF) significantly increases long-term mortality risk in patients following an acute myocardial infarction (AMI). Aggressive treatment of AF in AMI patients is crucial for reducing mortality.
Area of Science:
- Cardiology
- Internal Medicine
- Public Health
Background:
- Atrial fibrillation (AF) is a frequent complication of acute myocardial infarction (AMI).
- Improved therapeutic guidelines and pharmacological options exist for managing AMI and its complications.
- Contemporary research is needed to clarify AF's impact on long-term mortality post-AMI.
Purpose of the Study:
- To investigate the effect of atrial fibrillation (AF) on long-term mortality in patients experiencing an incident acute myocardial infarction (AMI).
- To analyze the association between AF and all-cause and cardiovascular disease mortality after AMI.
Main Methods:
- A cohort of 2,313 patients (aged 25-84) with incident AMI from 2009-2017 was analyzed.
- Median follow-up was 4.5 years, with survival and multivariable Cox regression analyses performed.
- Comparison between patients with AF (n=156) and sinus rhythm (SR, n=2,157) on admission ECG.
Main Results:
- Patients with AF were older and had more comorbidities, including hypertension and worse kidney function.
- Long-term all-cause mortality was significantly higher in the AF group (39.1%) compared to the SR group (16.7%).
- Multivariable analysis revealed a Hazard Ratio (HR) of 1.40 (95% CI [1.05-1.87]; p=0.023) for AF patients versus SR patients.
Conclusions:
- Atrial fibrillation is an independent risk factor for increased long-term mortality in patients with incident AMI.
- AF in AMI patients necessitates aggressive management strategies to mitigate mortality risks.
- Identifying and treating AF promptly in AMI survivors is essential for improving outcomes.
More Related Videos
Related Concept Videos
Myocarditis I: Introduction
Rheumatic Heart Disease I: Introduction
Myocarditis IV: Nursing Management
Myocarditis III: Medical Management
Mitral Regurgitation II: Clinical features and Diagnostic Tests

